This in vitro study was designed to examine the effect of some newly synthesized aminoalcanolic derivatives of xanthone (I, II) and aroxyalkyl derivatives of 2-methoxyphenylpiperazine (III, IV) having cardiovascular activity on the haemorheological parameters of RBCs from healthy individuals and patients with chronic venous disease. Additionally, the influence of compounds I-IV on some RBCs associated enzymes such as acetylcholinesterase (Ache), glucose-6-phosphate dehydrogenase (G6PD) and glutathione reductase (GR) as well as glutathione (GSH) content were determined in vitro in RBCs from healthy subjects. The study showed that compounds I, III and IV significantly increased RBCs deformability. Moreover, both xanthone derivatives reduced RBCs aggregation and diminished RBCs aggregates strength in all RBCs groups. Compounds II and III significantly improved Ache activity, whereas compounds I and II increased G6PD and GR activity and GSH level. In conclusion, compounds I, III and IV, which significantly improved RBCs deformability in vitro, may facilitate the passage of blood in the vascular system. Additionally, compounds I and II which inhibit RBCs aggregates formation in vitro may contribute to more rapid degradation of red blood cell aggregates in circulating blood.
PopelAS, JohnsonPC. Microcirculation and hemorheology. Annu Rev Fluid Mech. 2005;37:43–69.
2.
ParkY, BestCA, AuthT, GovNS, SafranSA, PopescuG, et al. Metabolic remodeling of the human red blood cell membrane. Proc Natl Acad Sci USA. 2010;107(4):1289–94.
3.
FrankeRP, ScharnweberT, FuhrmannR, WenzelF, KrügerA, MrowietzC, et al. Effect of radiographic contrast media on the spectrin/band3-network of the membrane skeleton of erythrocytes. PLoS One. 2014;9(2):e89512.
4.
BaskurtOK, MeiselmanHJ. Blood rheology and hemodynamics. Semin Thromb Hemost. 2003;29(5):435–50.
5.
WindbergerU, BartholovitschA, PlasenzottiR, KorakKJ, HeinzeG. Whole blood viscosity, plasma viscosity and erythrocyte aggregation in nine mammalian species: Reference values and comparison of data. Exp Physiol. 2003;88(3):431–40.
6.
JungF, MrowietzC, HieblB, FrankeRP, PindurG, SternitzkyR. Influence of rheological parameters on the velocity of erythrocytes passing nailfold capillaries in humans. Clin Hemorheol Microcirc. 2011;48(1):129–39.
7.
TzoulakiI, MurrayGD, LeeAJ, RumleyA, LoweGD, FowkesFG. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: The Edinburgh Artery Study. Circulation. 2007;115(16):2119–27.
8.
StachuraK, PietrzyckaA, MarchewkaA, Teległ ówA, DrożdżM, StępniewskiM, et al. Red blood cells deformability, aggregation parameters and plasma total antioxidant activity in blood of patients before and after hemodialysis. Acta Haematol Pol. 2008;39(3):461–7.
9.
KeymelS, HeissC, KleinbongardP, KelmM, LauerT. Impaired red blood cell deformability in patients with coronary artery disease and diabetes mellitus. Horm Metab Res. 2011;43(11):760–5.
10.
DonadelloK, PiagnerelliM, ReggioriG, GottinL, ScollettaS, OcchipintiG, et al. Reduced red blood cell deformability over time is associated with a poor outcome in septic patients. Microvasc Res. 2015;101:8–14.
11.
YagiH, SuminoH, AokiT, TsunekawaK, ArakiO, KimuraT, et al. Impaired blood rheology is associated with endothelial dysfunction in patients with coronary risk factors. Clin Hemorheol Microcirc. 2016;62(2):139–50.
12.
PabisiakA, BromboszczJ, KmiecS, DenduraM, DabrowskiZ, SmolenskiO. Changes in the complete blood count and blood rheology in patients after myocardial infarction participating in the rehabilitation programme. Clin Hemorheol Microcirc. 2015;61(3):541–7.
13.
MuravyovAV, YakusevichVV, ChuchkanovFA, MaimistovaAA, BulaevaSV, ZaitsevLG. Hemorheological efficiency of drugs, targeting on intracellular phosphodiesterase activity: In vitro study. Clin Hemorheol Microcirc. 2007;36(4):327–34.
14.
DormandyJA, ErnstE. Effects of buflomedil on erythrocytes deformability. Angiology. 1981;32(10):714–16.
15.
OttE, FazekasF, LechnerH. Haemorheological effects of pentoxifylline in disturbed blood flow behaviour in patients with cerebrovascular disease. Eur Neurol. 1983;22(Suppl. 1):105–7.
16.
FantinM, QuintieriL, KúszE, KisE, GlavinasH, FloreaniM, et al. Pentoxifylline and its major oxidative metabolites exhibit different pharmacological properties. Eur J Pharmacol. 2006;535(1-3):301–9.
17.
SłoczyńskaK, KózkaM, PękalaE, MarchewkaA, MaronaH. In vitro effect of pentoxifylline and lisofylline on deformability and aggregation of red blood cells from healthy subjects and patients with chronic venous disease. Acta Biochim Pol. 2013;60(1):129–35.
18.
PabisiakA, BromboszczJ, KmiecS, DenduraM, DabrowskiZ, SmolenskiO. Changes in the complete blood count and blood rheology in patients after myocardial infarction participating in the rehabilitation programme. Clin Hemorheol Microcirc. 2015;61(3):541–7.
19.
SalbaşK, GürlekA, AkyolT. In vitro effect of nicotine on red blood cell deformability in untreated and treated essential hypertension. Scand J Clin Lab Invest. 1994;54(8):659–63.
20.
BozzoJ, HernándezMR, OrdinasA. Reduced red cell deformability associated with blood flow and platelet activation: Improved by dipyridamole alone or combined with aspirin. Cardiovasc Res. 1995;30(5):725–30.
21.
AletA, AletN, DelannoyM, FontanaA, RiquelmeB. In vitro study of rheological effects of propofol on human erythrocyte membrane. Series Biomech. 2012;27(3-4):39–44.
22.
MaronaH, SzkaradekN, RapaczA, FilipekB, DybałaM, SiwekA, et al. Preliminary evaluation of pharmacological properties of some xanthone derivatives. Bioorg Med Chem. 2009;17(3):1345–52.
23.
MaronaH, KubackaM, FilipekB, SiwekA, DybałaM, SznelerE, et al. Synthesis, alpha-adrenoceptors affinity and alpha 1-adrenoceptor antagonistic properties of some 1,4-substituted piperazine derivatives. Pharmazie. 2011;66(10):733–9.
24.
KubackaM, MogilskiS, FilipekB, MaronaH. The hypotensive activity and alpha1-adrenoceptor antagonistic properties of some aroxyalkyl derivatives of 2-methoxyphenylpiperazine. Eur J Pharmacol. 2013;698(1-3):335–44.
25.
KubackaM, MogilskiSZ, FilipekB, MaronaH. Antiarrythmic properties of some 1,4-disubstituted piperazine derivatives with α1-adrenoceptor affinities. Eur J Pharmacol. 2013;720(1-3):237–46.
26.
RapaczA, SapaJ, BednarskiM, FilipekB, SzkaradekN, MaronaH. Antiarrhythmic activity of some xanthone derivatives with β1-adrenoceptor affinities in rats. Eur J Pharmacol. 2014;738:14–21.
27.
BaskurtOK, HardemanMR, RamplingMW, MeiselmanHJ, editors. Handbook of Hemorheology and Hemodynamics. Amsterdam: IOS Press; 2007.
28.
BeutlerE. Red cell metabolism: A manual of biochemical methods. New York, San Francisco and London: Grune and Stratton; 1984.
29.
OttP. Membrane acetylcholinesterases: Purification, molecular properties and interactions with amphiphilic environments. Biochim Biophys Acta. 1985;822(3-4):375–92.
30.
NowakE, WyrwiczG, DąbrowskiZ, SmoleńskiO, SpodarykK. Rheological and biochemical examination of red blood cells after treatment with different pharmacological and toxic substances. Clin Hemorheol Microcirc. 2002;26(2):91–7.
31.
BaskurtOK, TemizA, MeiselmanHJ. Effect of superoxide anions on red blood cell rheologic properties. Free Radic Biol Med. 1998;24(1):102–10.
32.
PandolfiPP, SonatiF, RiviR, MasonP, GrosveldF, LuzzattoL. Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J. 1995;14(21):5209–15.
33.
FujiiH, MiwaS. Red blood cell enzymes and their clinical application. Adv Clin Chem. 1998;33:1–54.
34.
LipovacV, GavellaM, VucićM, MrzljakV, RocićB. Effect of creatine on erythrocyte rheology in vitro. Clin Hemorheol Microcirc. 2000;22(1):45–52.
35.
MohandasN, ChasisJA, ShohetSB. The influence of membrane skeleton on red cell deformability, membrane material properties and shape. Semin Hematol. 1983;20(3):225–42.
36.
TakakuwaY. Protein 4.1, a multifunctional protein of the erythrocyte membrane skeleton: Structure and functions in erythrocytes and nonerythroid cells. Int J Hematol. 2000;72(3):298–309.
37.
GovNS, SafranSA. Red blood cell membrane fluctuations and shape controlled by ATP-induced cytoskeletal defects. Biophys J. 2005;88(3):1859–74.
